Lung Cancer 2024 REVIEW

Lung Cancer 2024 REVIEW

LUNG CANCER 2024 REVIEW Druggable since 2024: an overview of newly approved therapies for NSCLC Solange Peters Highlights of the year in targeted therapies Jordi Remon Highlights of the year in immunotherapies Hossein Borghaei  } 1 h 43 min Get Your CME...
EARLY NSCLC

EARLY NSCLC

EARLY NSCLC Welcome & introduction by host Jean Yannis Perentes To resect, or not to resect in early NSCLC: the who, when and how in thoracic surgery Jonathan Spicer The multidimensional role of radiotherapy in stage III NSCLC Salma Jabbour Transforming early NSCLC...
Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024) Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your CME...
Early NSCLC

Early NSCLC

Early NSCLC Welcome & introduction by host Isabelle Opitz Doing more with less: state of the art in tissue acquisition Carolin Steinack Current standards for pathology reporting in lung cancer Lukas Bubendorf Recent advances in thoracic surgery in lung cancer...
Lung Cancer 2023 Review

Lung Cancer 2023 Review

Lung Cancer 2023 Review Welcome & introduction by host Solange Peters Druggable since 2023: an overview of newly approved therapies Solange Peters Highlights of the year in immunotherapies Hossein Borghaei Highlights of the year in targeted therapies Pasi Jänne  } 1...